PRH1-TAS2R14: A Potential Drug Target and Biomarker (G106707243)

Target Name: PRH1-TAS2R14

NCBI ID: G106707243

PRH1-TAS2R14

Other Name(s): PRH1-TAS2R14 readthrough | Uncharacterized protein LOC106707243

PRH1-TAS2R14: A Potential Drug Target and Biomarker

PRH1-TAS2R14, also known as PRH1-TAS2R1, is a gene that encodes a protein involved in the intracellular signaling pathway known as the T cell signaling pathway. This pathway is crucial for the regulation of immune responses and is involved in the development and maintenance of T cell health. The T cell signaling pathway is a complex network of interactions that involve multiple protein interactions, including the interaction between the PRH1 protein and the TAS2R1 protein.

The PRH1-TAS2R14 protein is a key player in this pathway, as it plays a critical role in the regulation of T cell proliferation and differentiation. It has been shown to be involved in the development of T cell malignancy, as well as in the regulation of immune responses to viruses and other pathogens. The potential drug targets associated with this protein include those involved in the inhibition of its activity, as well as those involved in its regulation.

One of the potential drug targets for PRH1-TAS2R14 is the inhibition of its activity by small molecules such as inhibitors of protein tyrosination, which can lead to the inhibition of T cell proliferation and differentiation. Another potential drug target is the regulation of its expression by factors such as DNA methylation, which can affect the stability and localization of the protein.

In addition to its potential drug targets, PRH1-TAS2R14 also has potential as a biomarker for the diagnosis and monitoring of T cell malignancy. The T cell signaling pathway is a critical network for the regulation of immune responses, and alterations in this pathway have been implicated in the development of a wide range of T cell malignancies, including leukemia, lymphoma, and melanoma.

The PRH1-TAS2R14 protein is a key player in this pathway, and its regulation is closely associated with the development and progression of T cell malignancy. Therefore, targeting this protein has the potential to be a valuable drug and biomarker for the treatment of T cell malignancy. Further research is needed to fully understand the role of PRH1-TAS2R14 in T cell signaling and the potential drug targets associated with its activity.

Protein Name: PRH1-TAS2R14 Readthrough

The "PRH1-TAS2R14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRH1-TAS2R14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets